News

Xeris Pharmaceuticals, Inc. and Strongbridge Biopharma plc announced that they have entered into a definitive agreement under which Xeris will acquire Strongbridge for stock and…
Read More...

Boehringer Ingelheim announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for BI 425809 for the treatment of Cognitive Impairment…
Read More...

Shanghai Stock Exchange listed company HitGen Inc. (“HitGen”) announced that it has entered into a research collaboration agreement with Dorian Therapeutics, Inc. (“Dorian”), a private…
Read More...

Regeneron Pharmaceuticals, Inc. and Sanofi announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted positive opinions for…
Read More...

GlaxoSmithKline plc and Vir Biotechnology, Inc. announced that the European Medicines Agency’s (EMA) Committee for Human Medicinal Products (CHMP) has issued a positive scientific…
Read More...

AstraZeneca’s COVID-19 vaccine, Vaxzevria (ChAdOx1-S ), formerly AZD1222, has been granted a special approval for emergency use in Japan for active immunisation of individuals aged 18…
Read More...

The U.S. Food and Drug Administration approved Rybrevant (amivantamab-vmjw) as the first treatment for adult patients with non-small cell lung cancer whose tumors have specific types of…
Read More...

Takeda Pharmaceutical Company Limited announced that the Ministry of Health, Labour and Welfare (MHLW) granted special approval under article 14-3 of the Pharmaceuticals and Medical…
Read More...

AstraZeneca’s COVID-19 vaccine, Vaxzevria (ChAdOx1-S ), formerly AZD1222, has been granted a special approval for emergency use in Japan for active immunisation of individuals aged 18…
Read More...

Sorrento Therapeutics, Inc. announced receipt of clearance from the Brazilian regulatory agency (ANVISA) to proceed with a Phase 2 Pivotal clinical trial of COVI-MSC™, an injectable…
Read More...

GlaxoSmithKline has agreed with Innoviva, Inc (“Innoviva”) - a royalty management company - to sell all of its approximately 32 million shares of common stock of Innoviva back to…
Read More...

Arecor Limited the biopharmaceutical company advancing therapies to enable healthier lives,  announces that it has signed a formulation study partnership with Eli Lilly and Company…
Read More...

Pfizer Inc. and BioNTech SE announced a new agreement with the European Commission (EC) to supply 900 million doses of COMIRNATY, the companies’ COVID-19 vaccine, to the European Union…
Read More...

Thermo Fisher Scientific Inc. the world leader in serving science, and the University of California, San Francisco (UCSF) announced they have formed a strategic alliance to accelerate…
Read More...

Labcorp announced the expansion of its drug development offering in the Asia-Pacific region with the addition of bioanalytical services in Singapore. “Singapore is a crucial region…
Read More...

Veru Inc. an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate and breast cancer, announced that it has enrolled the first…
Read More...

Today, Mandos, LLC (Mandos) announced they have entered into an agreement with Vtesse, LLC, a wholly owned subsidiary of Mallinckrodt Pharmaceuticals (Mallinckrodt), a global…
Read More...

Exscientia, the clinical stage, Artificial Intelligence (AI)-driven pharmatech company, announced that it has entered into a collaboration agreement with Bristol-Myers Squibb Company.…
Read More...

Gamma Biosciences, a global life sciences company serving the advanced therapy market, announced that it has agreed to make a controlling investment in Mirus Bio, an innovator and…
Read More...

Bristol-Myers Squibb Company and Agenus Inc. announced that they have entered into a definitive agreement under which Bristol Myers Squibb will be granted a global exclusive license to…
Read More...